Search Results - "Moutsopoulos, Haralampos M"

Refine Results
  1. 1

    Sjögren's syndrome by Mavragani, Clio P, Moutsopoulos, Haralampos M

    Published in Annual review of pathology (01-01-2014)
    “…Sjögren's syndrome (SS) is a chronic autoimmune disorder that typically affects exocrine glands--mainly labial and lacrimal--leading to complaints of dry mouth…”
    Get full text
    Journal Article
  2. 2

    Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome by Christodoulou, Maria I, Kapsogeorgou, Efstathia K, Moutsopoulos, Haralampos M

    Published in Journal of autoimmunity (01-06-2010)
    “…Abstract Sjögren's syndrome (SS) is a chronic autoimmune exocrinopathy associated with variable degree of lymphocytic infiltration of the affected organs…”
    Get full text
    Journal Article
  3. 3

    Autoimmune rheumatic diseases: One or many diseases? by Moutsopoulos, Haralampos M.

    “…Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue…”
    Get full text
    Journal Article
  4. 4

    Clinically Significant Renal Involvement in Primary Sjögren's Syndrome: Clinical Presentation and Outcome by Goules, Andreas V., Tatouli, Ioanna P., Moutsopoulos, Haralampos M., Tzioufas, Athanasios G.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2013)
    “…Objective To estimate the prevalence and investigate the clinical features and the outcome of clinically significant renal involvement in a large cohort of…”
    Get full text
    Journal Article
  5. 5

    Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients by Papageorgiou, Aristea, Ziogas, Dimitrios C, Mavragani, Clio P, Zintzaras, Elias, Tzioufas, Athanasios G, Moutsopoulos, Haralampos M, Voulgarelis, Michael

    Published in PloS one (27-02-2015)
    “…Non-Hodgkin's lymphoma (NHL) development in Sjögren's syndrome (SS) remains a potentially lethal complication and efforts should focus on the identification of…”
    Get full text
    Journal Article
  6. 6

    Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome by Voulgarelis, Michael, Ziakas, Panayiotis D., Papageorgiou, Aristea, Baimpa, Evangelia, Tzioufas, Athanasios G., Moutsopoulos, Haralampos M.

    Published in Medicine (Baltimore) (01-01-2012)
    “…Sjögren syndrome (SS) has been associated with the development of non-Hodgkin lymphoma (NHL). From a cohort of 584 SS patients followed in our department from…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders by Plastiras, Sotiris C, Moutsopoulos, Haralampos M

    Published in Arrhythmia & electrophysiology review (01-04-2021)
    “…Rhythm and conduction disturbances and sudden cardiac death are important manifestations of cardiac involvement in autoimmune rheumatic diseases (ARD), which…”
    Get full text
    Journal Article Book Review
  10. 10

    Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and Evolution by Moyssakis, Ioannis, MD, FESC, FACC, Tektonidou, Maria G., MD, Vasilliou, Vassilios A., MD, Samarkos, Michael, MD, Votteas, Vassilios, MD, Moutsopoulos, Haralampos M., MD, FRCP, FACP

    Published in The American journal of medicine (01-07-2007)
    “…Abstract Purpose We evaluated the prevalence and progression of Libman-Sacks endocarditis in patients with systemic lupus erythematosus and any association…”
    Get full text
    Journal Article
  11. 11
  12. 12

    New advances in the classification, pathogenesis and treatment of Sjogrenʼs syndrome by Mavragani, Clio P, Nezos, Adrianos, Moutsopoulos, Haralampos M

    Published in Current opinion in rheumatology (01-09-2013)
    “…PURPOSE OF REVIEWIn the current review, we summarize the newly proposed classification criteria for Sjogrenʼs syndrome, recent findings of Sjogrenʼs syndrome…”
    Get full text
    Journal Article
  13. 13

    Toll-like Receptor-4 Is Up-Regulated in Hematopoietic Progenitor Cells and Contributes to Increased Apoptosis in Myelodysplastic Syndromes by MARATHEFTIS, Christos I, ANDREAKOS, Evangelos, MOUTSOPOULOS, Haralampos M, VOULGARELIS, Michael

    Published in Clinical cancer research (15-02-2007)
    “…Purpose: To investigate the function and expression of Toll-like receptors (TLR) in bone marrow cells of myelodysplastic syndrome (MDS) patients and to examine…”
    Get full text
    Journal Article
  14. 14

    Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome by Flessa, Christina-Maria, Zampeli, Evangelia, Evangelopoulos, Maria-Eleftheria, Natsis, Vasilis, Bodewes, Iris L A, Huijser, Erika, Versnel, Marjan A, Moutsopoulos, Haralampos M, Mavragani, Clio P

    Published in Frontiers in immunology (15-03-2022)
    “…Primary Sjögren's Syndrome (SS) is characterized by B lymphocyte hyperactivity with B cell activating factor (BAFF) acting as an important regulator. Single…”
    Get full text
    Journal Article
  15. 15

    Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies by Boutzios, Georgios, Koukoulioti, Eleni, Goules, Andreas V, Kalliakmanis, Ioannis, Giovannopoulos, Ilias, Vlachoyiannopoulos, Panayiotis, Moutsopoulos, Haralampos M, Tzioufas, Athanasios G

    Published in Frontiers in endocrinology (Lausanne) (22-04-2022)
    “…Hashimoto thyroiditis (HT) is an autoimmune disease which may result in extensive damage of the thyroid gland. Chronic atrophic gastritis (CAG), is the most…”
    Get full text
    Journal Article
  16. 16
  17. 17

    MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome by Fragkioudaki, Sofia, Nezos, Adrianos, Souliotis, Vassilis L., Chatziandreou, Ilenia, Saetta, Angelica A., Drakoulis, Nikolaos, Tzioufas, Athanasios G., Voulgarelis, Michael, Sfikakis, Petros P., Koutsilieris, Michael, Crow, Mary K., Moutsopoulos, Haralampos M., Mavragani, Clio P.

    Published in Scientific reports (04-08-2017)
    “…Primary Sjogren’s syndrome (pSS) confers increased risk for non-Hodgkin lymphoma (NHL) development. Two common polymorphisms, the c. 677C > T and c. 1298A > C,…”
    Get full text
    Journal Article
  18. 18

    β2 Glycoprotein I (β2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome by Sikara, Marina P., Routsias, John G., Samiotaki, Martina, Panayotou, George, Moutsopoulos, Haralampos M., Vlachoyiannopoulos, Panayiotis G.

    Published in Blood (21-01-2010)
    “…Antiphospholipid syndrome (APS) is an autoimmune thrombophilia characterized by arterial/venous thrombosis and/or pregnancy morbidity in the presence of…”
    Get full text
    Journal Article
  19. 19

    Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome by Manoussakis, Menelaos N, Fragoulis, George E, Vakrakou, Aigli G, Moutsopoulos, Haralampos M

    Published in PloS one (14-11-2014)
    “…Deficient efferocytosis (i.e. phagocytic clearance of apoptotic cells) has been frequently reported in systemic lupus erythematosus (SLE). Todate, patients…”
    Get full text
    Journal Article
  20. 20